A big barrier to novel drugs being used in treatment is that they need to be proved safe as well as effective
We propose repurposing existing drugs which are already known to be safe in humans.
By taking data from online clinical trial databases and abstracts from preprint servers proposing drugs for COVID-19 we combine this with structural information from approved drugs from drugbank we propose structurally similar drugs which may work in similar ways
Using drug-target information from STITCHdb we identify targets of drugs in existing trials, and look at other drugs targetting them as potential COVID-19 treatments
Current team Meabh MacMahon and Woochang Hwang (Mentor Namshik Han)